RxDB
ICD-9-CM Codes ICD-9-PCS Codes

3956 - Repair of blood vessel with tissue patch graft

Overview

GEM Conversion to ICD-10 PCS

Fs: 10000 – Supplement Pulmonary Trunk with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Pulmonary Trunk with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Pulmonary Trunk with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Pulmonary Trunk with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Pulmonary Trunk with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Pulmonary Trunk with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Pulmonary Trunk with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Pulmonary Trunk with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Pulmonary Trunk with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Superior Vena Cava with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Superior Vena Cava with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Superior Vena Cava with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Superior Vena Cava with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Superior Vena Cava with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Superior Vena Cava with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Superior Vena Cava with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Superior Vena Cava with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Superior Vena Cava with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Thoracic Aorta, Descending with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Zooplastic Tissue, Open Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Nonautologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Zooplastic Tissue, Percutaneous Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Nonautologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Zooplastic Tissue, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Thoracic Aorta, Ascending/Arch with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Internal Mammary Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Internal Mammary Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Innominate Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Innominate Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Innominate Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Subclavian Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Subclavian Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Subclavian Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Subclavian Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Subclavian Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Subclavian Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Axillary Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Axillary Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Axillary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Axillary Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Axillary Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Axillary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Brachial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Brachial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Brachial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Brachial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Brachial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Brachial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Ulnar Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Ulnar Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Ulnar Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Ulnar Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Ulnar Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Ulnar Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Radial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Radial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Radial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Radial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Radial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Radial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Hand Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Hand Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Hand Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Hand Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Hand Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Hand Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Intracranial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Intracranial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Intracranial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Common Carotid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Common Carotid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Internal Carotid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Internal Carotid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right External Carotid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right External Carotid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right External Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left External Carotid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left External Carotid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left External Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Vertebral Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Vertebral Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Vertebral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Vertebral Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Vertebral Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Vertebral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Face Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Face Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Face Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Temporal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Temporal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Temporal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Temporal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Temporal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Temporal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Thyroid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Thyroid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Thyroid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Thyroid Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Thyroid Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Thyroid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Upper Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Upper Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Upper Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Abdominal Aorta with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Abdominal Aorta with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Abdominal Aorta with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Celiac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Celiac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Celiac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Gastric Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Gastric Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Gastric Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Hepatic Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Hepatic Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Hepatic Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Splenic Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Splenic Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Splenic Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Superior Mesenteric Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Superior Mesenteric Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Superior Mesenteric Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Colic Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Colic Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Colic Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Colic Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Colic Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Colic Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Middle Colic Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Middle Colic Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Middle Colic Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Renal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Renal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Renal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Renal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Renal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Renal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Inferior Mesenteric Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Inferior Mesenteric Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Inferior Mesenteric Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Common Iliac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Common Iliac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Common Iliac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Common Iliac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Common Iliac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Common Iliac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Internal Iliac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Internal Iliac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Internal Iliac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Internal Iliac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Internal Iliac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Internal Iliac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right External Iliac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right External Iliac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right External Iliac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left External Iliac Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left External Iliac Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left External Iliac Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Femoral Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Femoral Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Femoral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Femoral Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Femoral Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Femoral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Popliteal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Popliteal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Popliteal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Popliteal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Popliteal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Popliteal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Anterior Tibial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Anterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Anterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Anterior Tibial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Anterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Anterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Posterior Tibial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Posterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Posterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Posterior Tibial Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Posterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Posterior Tibial Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Peroneal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Peroneal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Peroneal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Peroneal Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Peroneal Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Peroneal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Foot Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Foot Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Foot Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Foot Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Foot Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Foot Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Lower Artery with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Lower Artery with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Lower Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Azygos Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Azygos Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Azygos Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Hemiazygos Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Hemiazygos Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Hemiazygos Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Innominate Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Innominate Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Innominate Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Innominate Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Subclavian Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Subclavian Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Subclavian Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Subclavian Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Subclavian Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Subclavian Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Axillary Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Axillary Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Axillary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Axillary Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Axillary Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Axillary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Brachial Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Brachial Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Brachial Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Brachial Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Brachial Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Brachial Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Basilic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Basilic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Basilic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Basilic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Basilic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Basilic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Cephalic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Cephalic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Cephalic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Cephalic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Cephalic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Cephalic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Hand Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Hand Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Hand Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Hand Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Hand Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Hand Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Intracranial Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Intracranial Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Intracranial Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Internal Jugular Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Internal Jugular Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right External Jugular Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right External Jugular Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right External Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left External Jugular Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left External Jugular Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left External Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Vertebral Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Vertebral Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Vertebral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Vertebral Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Vertebral Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Vertebral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Face Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Face Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Face Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Face Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Face Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Face Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Upper Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Upper Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Upper Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Inferior Vena Cava with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Inferior Vena Cava with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Inferior Vena Cava with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Splenic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Splenic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Splenic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Gastric Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Gastric Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Gastric Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Esophageal Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Esophageal Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Hepatic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Hepatic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Hepatic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Superior Mesenteric Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Superior Mesenteric Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Superior Mesenteric Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Inferior Mesenteric Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Inferior Mesenteric Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Inferior Mesenteric Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Colic Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Colic Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Colic Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Portal Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Portal Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Portal Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Renal Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Renal Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Renal Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Renal Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Renal Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Renal Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Common Iliac Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Common Iliac Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Common Iliac Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Common Iliac Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Common Iliac Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Common Iliac Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right External Iliac Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right External Iliac Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right External Iliac Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left External Iliac Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left External Iliac Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left External Iliac Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Hypogastric Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Hypogastric Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Hypogastric Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Hypogastric Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Hypogastric Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Hypogastric Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Femoral Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Femoral Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Femoral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Femoral Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Femoral Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Femoral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Saphenous Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Saphenous Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Saphenous Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Saphenous Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Saphenous Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Saphenous Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Lesser Saphenous Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Lesser Saphenous Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Lesser Saphenous Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Lesser Saphenous Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Lesser Saphenous Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Lesser Saphenous Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Right Foot Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Right Foot Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Right Foot Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Left Foot Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Left Foot Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Left Foot Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Fs: 10000 – Supplement Lower Vein with Autologous Tissue Substitute, Open Approach
Fs: 10000 – Supplement Lower Vein with Autologous Tissue Substitute, Percutaneous Approach
Fs: 10000 – Supplement Lower Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach

Sibling Codes

Angioplasty of other non-coronary vessel(s)
Clipping of aneurysm
Other repair of aneurysm
Repair of arteriovenous fistula
Re-entry operation (aorta)
Reimplantation of aberrant renal vessel
Repair of blood vessel with tissue patch graft
Repair of blood vessel with synthetic patch graft
Repair of blood vessel with unspecified type of patch graft
Other repair of vessel

Parent Sibling Codes

Systemic to pulmonary artery shunt
Intra-abdominal venous shunt